Invokana Lawsuits
Play

Ross Feller Casey, one of the leading personal injury law firms in the U.S., is actively investigating lawsuits against the makers of Invokana on behalf of clients from across the nation who have suffered amputations or kidney failure as a result of taking the popular diabetes drug.

In May 2017, the U.S. Food and Drug Administration (FDA) required the makers of Invokana (canagliflozin), Invokamet and Invokamet XR to place black-box warning labels on the drugs after confirming that studies showed that patients who took them were twice as likely to need their legs or feet amputated.

In two clinical trials, researchers found that, over a year, twice as many patients given canagliflozin required amputations as those who took a placebo. Most of the amputations involved a foot or a toe. But some involved entire legs or more than one amputation, according to the FDA.

In adults with type 2 diabetes, Invokana, Invokamet and Invokamet XR are prescribed as a Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor to be used along with diet and exercise to lower blood sugar and improve glycemic control.

In addition to the latest warnings about amputations, the drug has been linked to cardiovascular problems, heart attacks, kidney failure and ketoacidosis, a serious condition caused by the buildup of acids in the blood.

To date, more than 225 lawsuits have been filed against the companies that manufactured and marketed the drug, including Janssen Pharmaceuticals, Johnson & Johnson, and Mitsubishi Tanabe Pharmaceuticals. The lawsuits allege the companies failed to warn of life-threatening risks, improperly marketed the drug, and designed a defective product that prevents the body from metabolizing excess glucose by directing it through the kidneys.

For an article on Invokana, The Legal Intelligencer turned to Ross Feller Casey attorney Brian J. McCormick, Jr. for his expertise on mass tort litigation.

Last year, McCormick told the nation’s oldest legal journal that he believed the Complex Litigation Center within the Philadelphia court system would eventually see numerous cases being filed there.

“It’s a blockbuster drug,” he told The Legal Intelligencer (read story here).

The FDA previously required that SGLT2 drugs, including Invokana, change their labels to warn about ketoacidosis as a possible side effect. Ketoacidosis is a serious condition with more than 200,000 cases reported annually in the U.S.

Are you wondering: How do I find an Invokana injury lawyer near me?

If you or someone you love suffered an amputation, cardiovascular problems, ketoacidosis or other serious injuries as a result of taking Invokana, Invokamet or Invokamet XR, you may be entitled to compensation through an Invokana lawsuit. You should contact one of our Invokana lawyers immediately for a free consultation.

Ross Feller Casey handles all its cases, including Invokana lawsuits, on a contingency basis, so you will not be charged unless a monetary recovery is made on your behalf.